178 related articles for article (PubMed ID: 18568209)
1. Mechanism of action of glucocorticoids in nasal polyposis.
Fernandes AM; Valera FC; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2008; 74(2):279-83. PubMed ID: 18568209
[TBL] [Abstract][Full Text] [Related]
2. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment.
Valera FC; Queiroz R; Scrideli C; Tone LG; Anselmo-Lima WT
Clin Exp Allergy; 2009 Jan; 39(1):81-8. PubMed ID: 19068102
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms underlying glucocorticoid resistance in chronic rhinosinusitis with nasal polyps].
Zhang YY; Lou HF; Wang CS; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):154-160. PubMed ID: 29429191
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid receptor expression and glucocorticoid therapeutic effect in nasal polyps.
Li P; Li Y; Li YQ; Yang QT; Zhang GH
Clin Invest Med; 2010 Jun; 33(3):E181-8. PubMed ID: 20519097
[TBL] [Abstract][Full Text] [Related]
5. Nuclear translocation of the glucocorticoid receptor in fibroblasts of asthmatic patients with nasal polyposis insensitive to glucocorticoid treatment.
Embid C; Fernández-Bertolín L; Pujols L; Alobid I; Mullol J; Picado C
Arch Bronconeumol; 2011 Mar; 47(3):115-21. PubMed ID: 21288619
[TBL] [Abstract][Full Text] [Related]
6. Expression of intercellular adhesion molecule-1 on the vascular endothelium in nasal polyps before, during and after topical glucocorticoid treatment.
Tingsgaard PK; Larsen PL; Bock T; Lange Vejlsgaard G; Tos M
Acta Otolaryngol; 1998 Jun; 118(3):404-8. PubMed ID: 9655217
[TBL] [Abstract][Full Text] [Related]
7. Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps.
Benson M; Carlsson L; Adner M; Jernås M; Rudemo M; Sjögren A; Svensson PA; Uddman R; Cardell LO
J Allergy Clin Immunol; 2004 Jun; 113(6):1137-43. PubMed ID: 15208596
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis.
Grzanka A; Misiołek M; Golusiński W; Jarząb J
Eur Arch Otorhinolaryngol; 2011 Feb; 268(2):247-53. PubMed ID: 20628753
[TBL] [Abstract][Full Text] [Related]
9. Steroid resistance in nasal polyposis: role of glucocorticoid receptor and TGF-beta1.
Aversa S; Ondolo C; Abbadessa G; Piccione F; Carriero V; Fulcheri A; Lauria A; De Francia S; Racca S
Rhinology; 2012 Dec; 50(4):427-35. PubMed ID: 23193535
[TBL] [Abstract][Full Text] [Related]
10. Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids.
Pujols L; Alobid I; Benítez P; Martínez-Antón A; Roca-Ferrer J; Fokkens WJ; Mullol J; Picado C
Allergy; 2008 Oct; 63(10):1377-86. PubMed ID: 18671773
[TBL] [Abstract][Full Text] [Related]
11. Changes of glucocorticoid receptor expression in the nasal polyps of patients with chronic sinusitis following treatment with glucocorticoid.
Watanabe S; Suzaki H
In Vivo; 2008; 22(1):37-42. PubMed ID: 18396779
[TBL] [Abstract][Full Text] [Related]
12. Expression of genes that encode the annexin-1 and galectin-1 proteins in nasal polyposis and their modulation by glucocorticoid.
Fernandes AM; Babeto E; Rahal P; Provazzi PJ; Hidalgo CA; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2010; 76(2):213-8. PubMed ID: 20549082
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory actions of glucocorticoids: molecular mechanisms.
Barnes PJ
Clin Sci (Lond); 1998 Jun; 94(6):557-72. PubMed ID: 9854452
[TBL] [Abstract][Full Text] [Related]
14. Topical budesonide treatment reduces endothelial expression of intercellular adhesion molecules (vascular cell adhesion molecule-1 and P-selectin) and eosinophil infiltration in nasal polyps.
Tingsgaard PK; Bock T; Larsen PL; Tos M
Acta Otolaryngol; 1999; 119(3):362-8. PubMed ID: 10380744
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical budesonide treatment on glucocorticoid receptor mRNA down-regulation and cytokine patterns in nasal polyps.
Henriksson G; Norlander T; Forsgren J; Stierna P
Am J Rhinol; 2001; 15(1):1-8. PubMed ID: 11258648
[TBL] [Abstract][Full Text] [Related]
16. Expression of glucocorticoid receptor mRNAs in glucocorticoid-resistant nasal polyps.
Choi BR; Kwon JH; Gong SJ; Kwon MS; Cho JH; Kim JH; Oh S; Roh HJ; Kim DE
Exp Mol Med; 2006 Oct; 38(5):466-73. PubMed ID: 17079862
[TBL] [Abstract][Full Text] [Related]
17. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma.
Umland SP; Schleimer RP; Johnston SL
Pulm Pharmacol Ther; 2002; 15(1):35-50. PubMed ID: 11969362
[TBL] [Abstract][Full Text] [Related]
18. Connectivity can be used to identify key genes in DNA microarray data: a study based on gene expression in nasal polyps before and after treatment with glucocorticoids.
Benson M; Steenhoff Hov DA; Clancy T; Hovig E; Rudemo M; Cardell LO
Acta Otolaryngol; 2007 Oct; 127(10):1074-9. PubMed ID: 17851899
[TBL] [Abstract][Full Text] [Related]
19. An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance.
Ingawale DK; Mandlik SK; Patel SS
J Complement Integr Med; 2015 Mar; 12(1):1-13. PubMed ID: 25503867
[TBL] [Abstract][Full Text] [Related]
20. Effect of glucocorticoids on nasal polyposis, with detection of inflammatory response by measurement of nitric oxide levels in nasal polyp tissue.
Bülbül T; Bülbül OG; Güçlü O; Bilsel AS; Gürsan SÖ
J Laryngol Otol; 2013 Jun; 127(6):584-9. PubMed ID: 23587256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
